Psio
Psychedelics induce a powerful state of heightened neuroplasticity — but the window is brief, and outcomes vary wildly. Most of the therapeutic potential goes untapped.
The neuroplastic opening closes before integration consolidates, leaving most of the therapeutic potential locked behind a single session.
Response varies widely across individuals — shaped by neurobiology, set, setting, and integration. Clinics can't predict, measure, or reinforce what's working.
Psio
Prep the brain. Capture the breakthrough. Reinforce the neural signature.
Psio
Each surface implements one phase of the loop — the same EEG-informed baseline travels from session to clinic to client.
Psio
The platform is working. The first sessions are on the calendar. The first clinic partner is engaged. What we need now is acceleration.
Facilitator portal, clinic dashboard, and client app — all running on real EEG hardware (Muse Athena), built pre-funding by the founding team. Active development continues toward production grade.
First sessions go live this month — the start of in-the-wild outcome data from the Psio platform.
Verbal commitment from MindSpa, a licensed healing center under Colorado's Natural Medicine Health Act — first pilot session planned for June.
Active discussions with additional Colorado and Oregon healing centers — building the pipeline behind MindSpa.
Psio
Psio is the precision neurofeedback layer for regulated psychedelic care. The product ships, the first clinic is signed, and the regulated market is open. We're looking for the right partners to accelerate.